ScreenerHero

IMCCIM Cannabis Corp.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · imcannabis.com
0.1128USDMkt Cap: 1.84M $P/E: —

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, an…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap1.84M $
Enterprise Value13.96M $
Revenue (TTM)45.80M $
Gross Profit9.69M $
Net Income (TTM)-11.32M $
Revenue/Share7.009 USD
Last Price0.1128 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.09
PEG—
EV/EBITDA-1.74
EV/Revenue0.30
P/S0.02
P/B-0.27
EPS (TTM)-2.53
EPS (Forward)-1.30
52W Range
0.108056% of range0.1165
52W High0.1165 USD
52W Low0.1080 USD
Profitability
Gross Margin17.70%
Oper. Margin-27.54%
EBITDA Margin-17.55%
Profit Margin-20.68%
ROE1319.23%
ROA-35.67%
Growth
Revenue Growth-40.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.72M $
CapEx (TTM)13.00K $
FCF Margin-4.64%
FCF Yield-115.58%
Net Debt12.21M $
Net Debt/EBITDA-1.52
Balance Sheet
Debt/Equity-18.96
Current Ratio0.56
Quick Ratio0.29
Book Value/Sh-0.4301 USD
Cash/Share0.0990 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 18, 2018
Splits
Last Split1:6
Split DateJul 12, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.02M
Float10.65M
Insiders12.07%
Institutions1.99%
Short Interest
Short Ratio0.1d
Short % Float5.85%
Short % Out.5.26%
Shares Short474.36K
Short (prev mo.)373.49K
Technical
SMA 500.1520 (-25.8%)
SMA 2000.7350 (-84.7%)
Beta2.11
S&P 52W Chg21.00%
Avg Vol (30d)803.81K
Avg Vol (10d)4.91M
Technical Indicators
RSI (14)38.4
MACD-0.0105
MACD Signal-0.0117
MACD Hist.+0.0011
BB Upper0.1376 USD
BB Middle0.1184 USD
BB Lower0.0993 USD
BB Width32.35%
ATR (14)0.0141 USD
Vol Ratio (20d)0.12x